Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Cusi

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Trends in Endocrinology and Metabolism: TEM|April 15, 2008
Thyroid function testing in psychiatric illness: Usefulness and limitationsR Arem, K Cusi
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistanceK Cusi, R DeFronzo
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|June 1, 1990
Value of sensitive thyrotropin measurement in ambulatory and hospitalized patientsR Arem, K Cusi, C Kiefe
The Journal of Clinical Endocrinology and Metabolism|November 1, 1996
Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitusK Cusi, A Consoli, R A DeFronzo
Diabetes Care|June 1, 1995
Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDMK Cusi, G R Cunningham, J P Comstock
Clinical Pharmacology and Therapeutics|December 30, 2016
Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development programR N Williams, C Filozof, B J Goldstein, et al.
Metabolism Open|December 9, 2025
Close multilevel links between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitusA G Holleboom, S M Francque, K Cusi, et al.
Alimentary Pharmacology & Therapeutics|May 5, 2017
Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitisM Kawaguchi-Suzuki, F Bril, S Kalavalapalli, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2010
Pioglitazone in the treatment of NASH: the role of adiponectinA Gastaldelli, S Harrison, R Belfort-Aguiar, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetesK Cusi, S Cukier, R A DeFronzo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Trends in Endocrinology and Metabolism: TEM|April 15, 2008
Thyroid function testing in psychiatric illness: Usefulness and limitationsR Arem, K Cusi
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Recombinant human insulin-like growth factor I treatment for 1 week improves metabolic control in type 2 diabetes by ameliorating hepatic and muscle insulin resistanceK Cusi, R DeFronzo
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|June 1, 1990
Value of sensitive thyrotropin measurement in ambulatory and hospitalized patientsR Arem, K Cusi, C Kiefe
The Journal of Clinical Endocrinology and Metabolism|November 1, 1996
Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitusK Cusi, A Consoli, R A DeFronzo
Diabetes Care|June 1, 1995
Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDMK Cusi, G R Cunningham, J P Comstock
Clinical Pharmacology and Therapeutics|December 30, 2016
Structure of proof of concept studies that precede a nonalcoholic steatohepatitis development programR N Williams, C Filozof, B J Goldstein, et al.
Metabolism Open|December 9, 2025
Close multilevel links between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitusA G Holleboom, S M Francque, K Cusi, et al.
Alimentary Pharmacology & Therapeutics|May 5, 2017
Concentration-dependent response to pioglitazone in nonalcoholic steatohepatitisM Kawaguchi-Suzuki, F Bril, S Kalavalapalli, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2010
Pioglitazone in the treatment of NASH: the role of adiponectinA Gastaldelli, S Harrison, R Belfort-Aguiar, et al.
The Journal of Clinical Endocrinology and Metabolism|March 10, 2001
Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetesK Cusi, S Cukier, R A DeFronzo, et al.
Pageof 2